AGP Picks
View all

Sci-Tech News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.

Press releases published on October 24, 2026

TGC 2026: Tec-Do Meluncurkan Navos Pro, AI for Work yang Berorientasi pada Hasil
TGC 2026:テック・ドゥ、ビジネス成果を重視した業務向けAI、「ナヴォス・プロ」を発表
TGC 2026: 테크두, 실질적 성과 창출에 초점 맞춘 업무용 AI 솔루션 ‘나보스 프로’ 출시
TGC 2026: Tec-Do Melancarkan Navos Pro untuk AI for Work Berorientasikan Hasil
TGC 2026: Tec-Do Lança Navos Pro, IA Voltada para Resultados no Trabalho
TGC 2026: Tec-Do เปิดตัว Navos Pro มุ่งพัฒนา AI เพื่อการทำงานที่มุ่งเน้นผลลัพธ์
Melbourne coach Dominik Kulewski's Weight Loss Lab clients have now lost about 3 tonnes combined
2026 National Poppy Campaign launches with a donation “first” … and stunning mural: Don’t forget to Remember
JelluTide Gummies Introduces Jellu Tide Multi-Ingredient Dietary Supplement Formulation
Quanta Presents Positive Clinical Combination Data in KRAS G12D-Mutant CRC at ESMO and Highlights Pan-KRAS Progress
Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors
DEEP Robotics Unveils Five Research Advances in Embodied AI
XBiotech gibt die Wahl von Sushma Shivaswamy und Jan-Paul Simard zu Co-Chief Executive Officers bekannt
XBiotech annonce la nomination de Sushma Shivaswamy et Jan-Paul Simard aux postes de co-directeurs généraux
NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma
NANOBIOTIX annonce les résultats complets de l’étude de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle immunitaires chez des patients atteints de mélanome cutané résistant aux anti-PD-1, en traitement de de…
KFSH Extends Emergency Access Through Virtual Care and Specialist Coordination
KFSH erweitert den Zugang zur Notfallversorgung durch virtuelle Versorgung und die Koordination durch Fachärzte
KFSH élargit l’accès aux urgences grâce aux soins virtuels et à la coordination des spécialistes
Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Sci-Tech News Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.